These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 10408394

  • 1. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
    Brasseur N, Ouellet R, La Madeleine C, van Lier JE.
    Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
    [Abstract] [Full Text] [Related]

  • 2. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
    Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA.
    Cancer Res; 2001 Mar 01; 61(5):1970-5. PubMed ID: 11280754
    [Abstract] [Full Text] [Related]

  • 3. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
    Mosa M, Zitko M, Poucková P.
    Neoplasma; 1997 Mar 01; 44(3):178-83. PubMed ID: 9372860
    [Abstract] [Full Text] [Related]

  • 4. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
    Kyriazi M, Alexandratou E, Yova D, Rallis M, Trebst T.
    Photodermatol Photoimmunol Photomed; 2008 Apr 01; 24(2):87-94. PubMed ID: 18353089
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
    Hu M, Brasseur N, Yildiz SZ, van Lier JE, Leznoff CC.
    J Med Chem; 1998 May 21; 41(11):1789-802. PubMed ID: 9599230
    [Abstract] [Full Text] [Related]

  • 6. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
    Boyle RW, Rousseau J, Kudrevich SV, Obochi M, van Lier JE.
    Br J Cancer; 1996 Jan 21; 73(1):49-53. PubMed ID: 8554982
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
    Cauchon N, Ali H, Hasséssian HM, van Lier JE.
    Photochem Photobiol Sci; 2010 Mar 21; 9(3):331-41. PubMed ID: 20221459
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA, Zaidi SI, Sprecher RC, Setrakian S, Stepnick DW, Oleinick NL, Mukhtar H.
    Laryngoscope; 1993 Sep 21; 103(9):967-75. PubMed ID: 8361317
    [Abstract] [Full Text] [Related]

  • 9. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
    Peng Q, Moan J.
    Br J Cancer; 1995 Sep 21; 72(3):565-74. PubMed ID: 7669563
    [Abstract] [Full Text] [Related]

  • 10. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS, Brasseur N, La Madeleine C, van Lier JE.
    Anticancer Res; 1996 Sep 21; 16(4A):1887-92. PubMed ID: 8712717
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma.
    Camerin M, Magaraggia M, Soncin M, Jori G, Moreno M, Chambrier I, Cook MJ, Russell DA.
    Eur J Cancer; 2010 Jul 21; 46(10):1910-8. PubMed ID: 20356732
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic, toxicological and phototherapeutic studies of phthalocyanine ZnPcCF3.
    Milla LN, Yslas EI, Cabral A, Durantini EN, Romanini S, Rivarola V, Bertuzzi M.
    Biomed Pharmacother; 2009 Mar 21; 63(3):209-15. PubMed ID: 18599256
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours.
    Chan WS, Brasseur N, La Madeleine C, Ouellet R, van Lier JE.
    Eur J Cancer; 1997 Oct 21; 33(11):1855-9. PubMed ID: 9470846
    [Abstract] [Full Text] [Related]

  • 17. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma.
    Camerin M, Moreno M, Marín MJ, Schofield CL, Chambrier I, Cook MJ, Coppellotti O, Jori G, Russell DA.
    Photochem Photobiol Sci; 2016 May 11; 15(5):618-25. PubMed ID: 27064601
    [Abstract] [Full Text] [Related]

  • 18. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG, Hasan T.
    Cancer Res; 1993 Jan 01; 53(1):153-7. PubMed ID: 8416739
    [Abstract] [Full Text] [Related]

  • 19. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
    Margaron P, Madarnas P, Quellet R, Van Lier JE.
    Anticancer Res; 1996 Jan 01; 16(2):613-20. PubMed ID: 8687105
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.